Skip to main content
The headquarters building of Mitsubishi Tanabe Pharma Corporation.

 

Morrison Foerster, Mori, Hamada & Matsumoto, and Ropes & Gray have advised U.S. investment fund Bain Capital on its planned 510-billion-yen ($3.3 billion) acquisition of Mitsubishi Tanabe Pharma Corporation from Mitsubishi Chemical Group Corporation.

The acquisition is part of Bain’s aggressive expansion of its Japanese portfolio, as it earmarks $31 billion for the country over the next five years. Last month, Bain added Japanese aircraft interior maker Jamco to its portfolio through a $634 million deal, on which Ropes, MHM and  Nishimura & Asahi received mandates

Additionally, in October last year, Bain acquired Red Baron Group, Japan’s largest used-bike dealer, for $694 million, with Ropes and Anderson Mori & Tomotsune advising the PE giant.

“Tanabe Pharma has been delivering innovative medicines to Japanese patients for centuries, and we are proud to partner with MTPC and support its next phase of growth and evolution,” said Masa Suekane, a partner and head of Japan healthcare, industrials and financial services at Bain Capital Private Equity.  

The seller, Mitsubishi Chemical said it had made the sale as it was not in a position to provide the large-scale investment necessary to strengthen Mitsubishi Tanabe's research and development capacity.

Private equity-led buyouts are booming in Japan as companies increasingly carve out non-core businesses, under pressure from Japanese authorities to raise corporate and shareholder value.

The Ropes & Gray team was led in Tokyo by private equity partner Tsuyoshi Imai and finance partner Ben Morris, supported by associates Lucas Adams, Takashi Nakamura and Alex Nakayama. The London team advising on antitrust aspects included litigation & enforcement partner Ruchit Patel and associates Olivia Bennett and Katie Gerasimidis.

The MHM team comprised partners Hajime TanahashI, Rintaro Shinohara and Yusuke Takamiya, and counsel Hiroko Kasama.

The MoFo team was led by Tokyo-based M&A/PE partners Jeremy White and Randy Laxer, and included of counsel Takaki Sato and associates Bryce Gray, Ganesh Vaheisvaran, Ning Ning, Yusaku Narita, Agnes Hannah Petrucione, and Kasumi Matsukura.

 

TO CONTACT EDITORIAL TEAM, PLEASE EMAIL ALBEDITOR@THOMSONREUTERS.COM

Related Articles

SAM, JSA advise on Bajaj Group's $2.8 bln buyout of Allianz's stake in insurance JV

by Nimitt Dixit |

Shardul Amarchand Mangaldas & Co. has advised Bajaj Finserv on the proposed acquisition of Allianz SE's entire 26 percent promoter stake in their insurance joint ventures, Bajaj Allianz General Insurance Company (BAGIC) and Bajaj Allianz Life Insurance Company (BALIC).

Trilegal, CAM advise on $900 mln Brookfield-Gentari deal amid renewable M&A surge

by Nimitt Dixit |

Trilegal and Cyril Amarchand Mangaldas have advised on Brookfield Asset Management's $900 million sale of a 1.6 GW portfolio of solar and wind assets in India to Gentari Renewables India, a Petronas Group company.

Trilegal, CAM, Khaitan advise on $300 mln EnerGrid green energy platform

by Nimitt Dixit |

Trilegal and Cyril Amarchand Mangaldas have advised Norwegian and British investors on the formation of $300 million green energy platform EnerGrid, in partnership with IndiGrid, the Mumbai-based power transmission infrastructure investment trust backed by KKR.